Back
Keros Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
47
KROS
Keros Therapeutics, Inc.
Last Price:
$16.56
Seasonality Move:
-4.37%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KROS is experiencing selling pressure, which indicates risk of future bearish movement.
Keros Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 17.46 | Sell |
| 20-day SMA: | 18.15 | Sell |
| 50-day SMA: | 19.33 | Sell |
| 200-day SMA: | 16.02 | Buy |
| 8-day EMA: | 17.35 | Sell |
| 20-day EMA: | 17.99 | Sell |
| 50-day EMA: | 18.35 | Sell |
| 200-day EMA: | 18.68 | Sell |
Keros Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.58 | Sell |
| Relative Strength Index (14 RSI): | 33.08 | Sell |
| Chaikin Money Flow: | -169074 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (17.53 - 19.17) | Sell |
| Bollinger Bands (100): | (15.54 - 19.76) | Sell |
Keros Therapeutics, Inc. Technical Analysis
| Jan 30 | Feb 2 | Feb 3 | Feb 4 | Feb 5 | Feb 6 | Feb 9 | Feb 10 | Feb 11 | Feb 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | Feb | |||||||||
| 30 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Keros Therapeutics, Inc. Stock
Is Keros Therapeutics, Inc. Stock a Buy?
-
Keros Therapeutics, Inc. share price is 16.61 while KROS 8-day simple moving average is 17.46, which is a Sell signal.
-
The stock price of KROS is 16.61 while Keros Therapeutics, Inc. 20-day SMA is 18.15, which makes it a Sell.
-
Keros Therapeutics, Inc. 50-day simple moving average is 19.33 while KROS share price is 16.61, making it a Sell technically.
-
KROS stock price is 16.61 and Keros Therapeutics, Inc. 200-day simple moving average is 16.02, creating a Buy signal.
KROS Technical Analysis vs Fundamental Analysis
Sell
47
Keros Therapeutics, Inc. (KROS)
is a Sell
Is Keros Therapeutics, Inc. a Buy or a Sell?
-
Keros Therapeutics, Inc. stock is rated a SellThe current Keros Therapeutics, Inc. [KROS] share price is $16.61. The Score for KROS is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
Keros Therapeutics, Inc. Stock Info
Market Cap:
506M
Price in USD:
16.61
Share Volume:
209.7K
Keros Therapeutics, Inc. 52-Week Range
52-Week High:
22.55
52-Week Low:
9.12
Sell
47
Keros Therapeutics, Inc. (KROS)
is a Sell
Keros Therapeutics, Inc. Share Price Forecast
-
What is the Keros Therapeutics, Inc. stock price today?The Keros Therapeutics, Inc. stock price is 16.61 USD today.
-
Will KROS stock go up or go down?Keros Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Keros Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Keros Therapeutics, Inc. is overvalued.
Is Keros Therapeutics, Inc. Stock a Buy?
-
Keros Therapeutics, Inc. share price is 16.61 while KROS 8-day exponential moving average is 17.35, which is a Sell signal.
-
The stock price of KROS is 16.61 while Keros Therapeutics, Inc. 20-day EMA is 17.99, which makes it a Sell.
-
Keros Therapeutics, Inc. 50-day exponential moving average is 18.35 while KROS share price is 16.61, making it a Sell technically.
-
KROS stock price is 16.61 and Keros Therapeutics, Inc. 200-day simple moving average is 18.68, creating a Sell signal.
Fundamental Analysis of Keros Therapeutics, Inc.
Is Keros Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, a decrease this year of $5.81 per share, and a decrease next year of $0.79 per share.
Technical Analysis of Keros Therapeutics, Inc.
Should I short Keros Therapeutics, Inc. stock?
-
KROS Moving Average Covergence Divergence (MACD) indicator is -0.58, suggesting Keros Therapeutics, Inc. is a Sell
-
Keros Therapeutics, Inc. Relative Strength Index (RSI) is 33.08, which suggest Keros Therapeutics, Inc. is oversold
-
The Bollinger Bands (25) for Keros Therapeutics, Inc. is (17.53 - 19.17), which suggest Keros Therapeutics, Inc. is a Sell
-
The Bollinger Bands (100) for Keros Therapeutics, Inc. is (15.54 - 19.76), which suggest Keros Therapeutics, Inc. is a Sell
* Keros Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.